Riskpilot← Back to searchSign inGet full accessFCH Medical AB
ABActiveOrg 5593205494Skanstorget 1General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2024
SEK 0
EBITDA margin
—
-109% vs 2023
Equity ratio
73.1%
Financial strength
Net profit 2024
SEK -21K
-110% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -22K | -109% |
| Net profit | SEK -21K | -110% |
| Total assets | SEK 119K | -66% |
| Equity | SEK 87K | -62% |
| Employees | 0 | — |
Legal name
FCH Medical AB
Org number
5593205494
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 juni 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Legitimerad läkare, medicinsk konsultationsverksamhet samt därmed förenlig verksamhet riktad mot regioner och privata aktörer inom hälso- och sjukvård. Förvaltning av eget kapital såsom värdepapper, aktier, fonder.
Address
Skanstorget 1
Email
filip.hallgren@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 345 | 0 |
| Staff expenses | — | — | — | −0 |
| EBITDA | — | — | 255 | −22 |
| Depreciation & amort. | −0 | −0 | −0 | — |
| EBIT | 0 | 0 | 255 | −22 |
| Net financials | — | — | — | 1 |
| Profit before tax | 0 | 0 | 256 | −21 |
| Tax | −0 | −0 | −53 | — |
| Net profit | 0 | 0 | 203 | −21 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 25 | 25 | 348 | 119 |
| Equity | 25 | 25 | 228 | 87 |
| Long-term debt | 0 | 0 | 0 | — |
| Short-term debt | 0 | 0 | 120 | 32 |
| Total debt | — | — | 120 | 32 |
EBITDA margin
-2212600.0%
This company
15.8%
Market median
-14003897% vs market
20212024
Equity ratio
73.1%
This company
38.2%
Market median
+91% vs market
20212024
Return on equity
-24.2%
This company
18.4%
Market median
-232% vs market
20212024
Net profit margin
-2105800.0%
This company
8.1%
Market median
-25997631% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FCH Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Filip Ceasar Hallgren | Chief Executive Officer | 0 companies |
| Per Magnus Hallgren | Deputy Board Member | 0 companies |